Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
19.95
-0.75 (-3.62%)
At close: Apr 10, 2026, 4:00 PM EDT
20.30
+0.35 (1.76%)
After-hours: Apr 10, 2026, 7:15 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $2.85 billion as of April 10, 2026. Its market cap has increased by 1,609.84% in one year.
Market Cap
2.85B
Enterprise Value
2.54B
1-Year Change
1,609.84%
Ranking
Category
Stock Price
$19.95
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $2.85B, an increase of 1,721.20%. That is a compound annual growth rate of 79.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 2.85B | 138.56% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.04B |
| Arcutis Biotherapeutics | 3.04B |
| Tarsus Pharmaceuticals | 3.02B |
| Alumis | 3.00B |
| Travere Therapeutics | 2.95B |
| Arcus Biosciences | 2.87B |
| Vera Therapeutics | 2.85B |
| IDEAYA Biosciences | 2.72B |